Free Trial
NASDAQ:MGCD

(MGCD) (MGCD) Stock Price, News & Analysis

→ The #1 Biotech Stock to Have on Your Radar in 2024… (From Huge Alerts) (Ad)
Free MGCD Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$11.03
▼
$11.03
50-Day Range
N/A
52-Week Range
$6.24
▼
$11.20
Volume
N/A
Average Volume
15,965 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis

About (MGCD)

MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs). Its cardiorespiratory diagnostic products measure flow and respiratory pressures and, in most cases analyze the inhaled and exhaled gases, such as oxygen and carbon dioxide. Its products include pulmonary function (PFT) and gas exchange (GX) testing products. The Company's pulmonary function products are divided into four product categories: Spirometry, Complete Pulmonary Function, Body Plethysmography and Specialty Products.

MGCD Stock News Headlines

January 9, 2024 | msn.com
Sonu Sood’s ‘Fateh’ is a cinematic tribute to cybercrime victims
December 31, 2023 | msn.com
Lakers' LeBron James irate after foot on line discounts potential tying shot in loss to Timberwolves
April 24, 2024 | Huge Alerts (Ad)
The #1 Biotech Stock to Have on Your Radar in 2024…
Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!
November 6, 2023 | msn.com
‘Defuse it quickly;’ Police arrest Springfield student who brought gun to football game
April 5, 2023 | reuters.com
Spencer Torkelson knocks in three as Tigers beat Astros
February 11, 2023 | msn.com
Busy Wednesday schedule kept Jenna Ortega from returning to You Season 4
December 29, 2022 | msn.com
Wrexham science discovery centre to launch Monday warm hub drop in sessions
December 17, 2022 | msn.com
F1 News: 2023 Aston Martin AMR23 Reveal Date Announced
April 24, 2024 | Huge Alerts (Ad)
The #1 Biotech Stock to Have on Your Radar in 2024…
Revenues exploding, a $18.70 price target, and highly lucrative addressable markets make this one you cannot ignore!
October 25, 2022 | msn.com
The Northern Belle train returns to Grantham for rare appearance this Christmas
September 28, 2022 | msn.com
Open Thread: Buffalo Sabres vs. Columbus Blue Jackets (Preseason)
August 18, 2022 | msn.com
L.A. County authorities search for woman, 23, missing since July
See More Headlines
Receive MGCD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (MGCD) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/07/2016
Today
4/24/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:MGCD
Previous Symbol
NASDAQ:ANGN
CUSIP
N/A
CIK
815093
Web
mgcdiagnostics.com
Phone
+1-651-4844874
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover
12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Greg Greenberg
    Chairman of the Board
  • Matthew S. Margolies (Age 50)
    President
  • Todd M. Austin (Age 54)
    Chief Executive Officer
  • Larry Robert Degen (Age 62)
    Interim Chief Financial Officer, Chief Accounting Officer, Secretary
  • Hendrik Struik (Age 49)
    Independent Director

MGCD Stock Analysis - Frequently Asked Questions

How were (MGCD)'s earnings last quarter?

(MGCD) (NASDAQ:MGCD) announced its quarterly earnings data on Wednesday, September, 7th. The medical equipment provider reported $0.06 earnings per share for the quarter. The medical equipment provider earned $9.90 million during the quarter, compared to analyst estimates of $9.20 million.

What other stocks do shareholders of (MGCD) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (MGCD) investors own include Allena Pharmaceuticals (ALNA), Akers Biosciences (AKER), Ampliphi Biosciences (APHB), Veru (VERU), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), Achieve Life Sciences (ACHV), AcelRx Pharmaceuticals (ACRX), Acacia Research (ACTG) and Achaogen (AKAO).

This page (NASDAQ:MGCD) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners
The #1 Biotech Stock to Have on Your Radar in 2024…
Huge Alerts
He Is Giving Away Bitcoin
Crypto Swap Profits
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
Fed launches fourth dollar overhaul
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing